American Society of Clinical Oncology, Journal of Clinical Oncology, 32(41), p. 5015-5024, 2023
DOI: 10.1200/jco.22.02639
Full text: Download
Upfront combination therapy in 81 chemotherapy/ARSI-naïve patients with mCRPC was well tolerated with improved PFS.